Age-Related Muscle Loss (Sarcopenia): Mechanisms, Diagnosis, and Treatment

Sarcopenia (Greek: sarx flesh + penia loss) is the age-related progressive loss of muscle mass, strength, and function. It begins ~30s, accelerates after 60, and affects 10–30% of community-dwelling older adults.

Multifactorial Pathophysiology

MechanismKey Changes
NeuromuscularMotor unit loss (denervation), remodeling (collateral reinnervation → larger, fewer units), ↓firing rate, ↓proprioception
Muscle FiberType II (fast) atrophy > Type I; fiber number ↓; satellite cell dysfunction; mitochondrial DNA mutations, ↓biogenesis
Protein TurnoverAnabolic resistance (blunted mTOR response to protein/insulin), ↑ubiquitin-proteasome, ↑autophagy, ↑inflammatory cytokines (IL-6, TNF-α)
Hormonal↓Testosterone, ↓GH/IGF-1, ↓DHEA, ↑cortisol, insulin resistance, ↓vitamin D
VascularEndothelial dysfunction → ↓capillary density, ↓nutrient/O₂ delivery
Behavioral↓Physical activity, ↓protein intake (anorexia of aging), ↓sunlight

Clinical Consequences

  • Physical: Gait slowing, fall risk ↑ 2–3x, disability (ADL/IADL), frailty phenotype.
  • Metabolic: Insulin resistance, type 2 diabetes (muscle = major glucose disposal site).
  • Clinical outcomes: Hospitalization, post-surgical complications, mortality ↑.
  • Economic: US costs ~$18B/year (direct).

Diagnosis (EWGSOP2 / AWGS 2019)

  1. Case finding: SARC-F questionnaire (Strength, Assistance walking, Rise from chair, Climb stairs, Falls).
  2. Strength: Handgrip (<27 kg M, <16 kg F) or chair stand (≥15 sec ×5).
  3. Mass: DXA (appendicular lean mass/ht² <7.0 kg/m² M, <5.5 kg/m² F) or BIA.
  4. Performance: Gait speed <0.8 m/s, SPPB ≤8, 400m walk >6 min → severe sarcopenia.

Evidence-Based Interventions

Exercise (Cornerstone)

  • Progressive Resistance Training (PRT): 2–3×/wk, 8–12 reps × 2–3 sets, 70–85% 1RM → ↑mass, strength, power, function.
  • Power training: High-velocity concentric — improves functional tasks more than strength alone.
  • Multicomponent: Balance, aerobic, flexibility.

Nutrition

  • Protein: 1.2–1.6 g/kg/day; 25–30g/meal (leucine threshold ~2.5g); whey, dairy, lean meat, soy.
  • Vitamin D: 800–2000 IU/day to maintain 25(OH)D >30 ng/mL.
  • Omega-3 (2–3g EPA/DHA): Anti-inflammatory, may enhance anabolic sensitivity.
  • Creatine monohydrate (3–5g/day): Adjunct to PRT — ↑strength, lean mass.

Pharmacologic (Investigational)

Myostatin inhibitors, SARMs, GH/IGF-1, testosterone (controversial), bimagrumab — not standard of care; only in trials.

Key message: Sarcopenia is preventable and treatable. Resistance exercise + adequate protein is the most potent non-pharmacologic intervention at any age. Start early, progress gradually, sustain lifelong.

Muscle Strains - Related Articles